Aignostics vs DNAnexus
Side-by-side comparison of AI visibility scores, market position, and capabilities
Aignostics is a Berlin-based computational pathology company applying AI to histopathology image analysis for drug development and clinical diagnostics; raised €45M+ total including a €37M Series B in 2024;
About
Aignostics is a Berlin-based precision pathology company founded in 2019 as a spinout from Charité – Universitätsmedizin Berlin, one of Europe''s largest university hospitals. The company develops foundation models and AI-powered image analysis tools for computational pathology — applying deep learning to digitized histopathology slides (whole slide images) to detect, classify, and quantify cellular and tissue features at scale. Its technology enables pharmaceutical companies, contract research organizations (CROs), and diagnostic laboratories to analyze tissue samples faster, more consistently, and with greater quantitative depth than human pathologists alone.
DNAnexus is the leading precision health data cloud, managing 65+ petabytes of biomedical data for 12,000+ users across 48 countries; $200M Series I led by Blackstone Growth; serves 7 of top 10 pharma and 8 of top 10 diagnostics companies.
About
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a secure, scalable, and regulatory-compliant cloud environment where pharmaceutical companies, genomics labs, biobanks, health systems, and research institutions can store, analyze, and share multimodal biomedical data — including genomic sequences, clinical records, imaging, and real-world evidence. The platform is purpose-built for the data types, compliance requirements, and computational workloads unique to biomedical research and precision medicine development.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.